Biotricity, Inc. (BTCY)

USD 0.5

(2.04%)

Gross Profit Summary of Biotricity, Inc.

Biotricity, Inc.'s latest annual gross profit in 2024 was 8.35 Million USD , up 53.55% from previous year.
Biotricity, Inc.'s latest quarterly gross profit in 2024 FY was 8.35 Million USD , up 53.55% from previous quarter.
Biotricity, Inc. reported a annual gross profit of 5.44 Million USD in annual gross profit 2023, up 19.08% from previous year.
Biotricity, Inc. reported a annual gross profit of 4.57 Million USD in annual gross profit 2022, up 259.08% from previous year.
Biotricity, Inc. reported a quarterly gross profit of 1.91 Million USD for 2024 Q1, up 24.89% from previous quarter.
Biotricity, Inc. reported a quarterly gross profit of 2.16 Million USD for 2024 Q3, up 8.44% from previous quarter.

Annual Gross Profit Chart of Biotricity, Inc. (2024 - 2014)

Historical Annual Gross Profit of Biotricity, Inc. (2024 - 2014)

Year	Gross Profit	Gross Profit Growth
2024	8.35 Million USD	53.55%
2023	5.44 Million USD	19.08%
2022	4.57 Million USD	259.08%
2021	1.27 Million USD	162.0%
2020	485.77 Thousand USD	711.45%
2019	59.86 Thousand USD	0.0%
2018	- USD	0.0%
2017	- USD	0.0%
2016	- USD	0.0%
2015	- USD	0.0%
2014	- USD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 FY	8.35 Million USD	53.55%
2024 Q1	1.91 Million USD	24.89%
2024 Q3	2.16 Million USD	8.44%
2024 Q4	2.27 Million USD	4.81%
2024 Q2	1.99 Million USD	4.31%
2023 Q3	1.4 Million USD	9.51%
2023 Q2	1.28 Million USD	4.5%
2023 FY	5.44 Million USD	19.08%
2023 Q1	1.22 Million USD	-14.96%
2023 Q4	1.53 Million USD	9.47%
2022 Q4	1.44 Million USD	74.66%
2022 Q3	824.83 Thousand USD	-27.3%
2022 Q2	1.13 Million USD	-3.03%
2022 Q1	1.17 Million USD	168.16%
2022 FY	4.57 Million USD	259.08%
2021 Q1	250.55 Thousand USD	810.45%
2021 FY	1.27 Million USD	162.0%
2021 Q2	135.28 Thousand USD	-46.0%
2021 Q3	141.88 Thousand USD	4.88%
2021 Q4	436.34 Thousand USD	207.52%
2020 Q2	231.69 Thousand USD	31.33%
2020 Q3	281.11 Thousand USD	21.33%
2020 FY	485.77 Thousand USD	711.45%
2020 Q1	176.41 Thousand USD	1169.35%
2020 Q4	-35.26 Thousand USD	-112.55%
2019 Q1	17.66 Thousand USD	0.0%
2019 FY	59.86 Thousand USD	0.0%
2019 Q3	90.13 Thousand USD	139.46%
2019 Q2	37.64 Thousand USD	113.15%
2019 Q4	13.89 Thousand USD	-84.58%
2018 Q1	- USD	0.0%
2018 Q2	- USD	0.0%
2018 Q3	- USD	0.0%
2018 Q4	- USD	0.0%
2018 FY	- USD	0.0%
2017 Q1	- USD	0.0%
2017 Q4	- USD	0.0%
2017 FY	- USD	0.0%
2017 Q3	- USD	0.0%
2017 Q2	- USD	0.0%
2016 Q2	- USD	0.0%
2016 FY	- USD	0.0%
2016 Q4	- USD	0.0%
2016 Q3	- USD	0.0%
2016 Q1	- USD	0.0%
2015 Q1	- USD	0.0%
2015 Q2	- USD	0.0%
2015 Q3	- USD	0.0%
2015 FY	- USD	0.0%
2014 FY	- USD	0.0%

Peer Gross Profit Comparison of Biotricity, Inc.

Name	Gross Profit	Gross Profit Difference
Acutus Medical, Inc.	-3.13 Million USD	366.378%
Cell MedX Corp.	- USD	-Infinity%
Dynatronics Corporation	7.63 Million USD	-9.447%
Nemaura Medical Inc.	-1.47 Million USD	665.993%
PetVivo Holdings, Inc.	739.52 Thousand USD	-1029.951%
RetinalGenix Technologies Inc.	-100.00 USD	8356381.0%
Sonendo, Inc.	10.72 Million USD	22.064%
Telesis Bio, Inc.	16.95 Million USD	50.7%
Talis Biomedical Corporation	371 Thousand USD	-2152.367%
Viveve Medical, Inc.	620 Thousand USD	-1247.787%